Psilocybin-assisted therapies are attracting considerable interest due to their ability to facilitate profound emotional processes and promote significant change in individuals with difficulties that are resistant to other treatments. Under controlled doses and in a safe environment, psilocybin can generate states of introspection that help individuals understand internal patterns, release blockages, and promote greater psychological clarity.
Psilocybin-assisted therapies are conducted within very rigorous clinical protocols, with professional support before, during, and after the experience to properly integrate the insights gained. Current research suggests a promising role in areas such as depression, anxiety, and trauma coping, always within specialised therapeutic frameworks.
This type of intervention is carried out within very rigorous clinical protocols, with professional support before, during and after the experience to properly integrate the insights gained. Current research suggests a promising role in areas such as depression, anxiety and trauma coping, always within specialised therapeutic frameworks.
-


📢 MINI CONFERENCE: PSYCHEDELICS AND MENTAL HEALTH 2026
On 20 March, Málaga will host a series of talks exploring the relationship between psychedelics and mental health. Specialists and professionals will discuss current research, their therapeutic potential and the challenges of…
-


Psychedelic Substances And Their Use In Contemporary Psychiatry
Psychiatry is undergoing a renaissance in the use of psychedelic substances to treat treatment-resistant depression, anxiety, and PTSD. A look at their history, prohibition, and the recognition owed to the indigenous peoples…
-


Rewiring the Soul: 5 Surprising Ways Psychedelics Reshape Who We Are
For centuries we believed personality was fixed, carved in stone by adulthood. A new systematic review — analyzing 48 studies on psilocybin, LSD, and ayahuasca — suggests otherwise: our deepest traits, from…
-


The First Training Seminar on Psilocybin-Assisted Therapy Comes to Madrid
First training seminar on psilocybin-assisted therapy in Spain. Three days of clinical training in Madrid, November 2026. Organised by Clínica Synaptica.
-


Psilocybin – what is it, and what is its current legal status?
Psilocybin is a naturally occurring psychedelic found in certain mushrooms with a long history of ritual use. Research shows it can alter perception, mood and sense of self, often producing meaningful or…
-


Microdosing psychedelics: potential benefits and current evidence
Microdosing psychedelics involves taking sub-perceptual doses of substances such as psilocybin or LSD with the aim of improving mood, cognition and emotional wellbeing. This article reviews current scientific evidence on microdosing, including…
-


Ketamine vs. psilocybin therapy: a comparative overview
This article compares ketamine and psilocybin-assisted therapies, outlining differences in legality, mechanisms of action, therapeutic uses, safety profiles and patient experience. Ketamine is legally available and offers rapid symptom relief through glutamatergic…
-


Psilocybin and depression
Psilocybin-assisted therapy is emerging as a promising approach for depression, particularly treatment-resistant cases where standard antidepressants show limited efficacy and burdensome side effects. Research suggests psilocybin can produce rapid and sustained reductions…
